Correlation Between Viking Therapeutics and Travere Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Travere Therapeutics, you can compare the effects of market volatilities on Viking Therapeutics and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Travere Therapeutics.

Diversification Opportunities for Viking Therapeutics and Travere Therapeutics

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Viking and Travere is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Travere Therapeutics go up and down completely randomly.

Pair Corralation between Viking Therapeutics and Travere Therapeutics

Given the investment horizon of 90 days Viking Therapeutics is expected to under-perform the Travere Therapeutics. In addition to that, Viking Therapeutics is 1.32 times more volatile than Travere Therapeutics. It trades about -0.25 of its total potential returns per unit of risk. Travere Therapeutics is currently generating about 0.08 per unit of volatility. If you would invest  1,776  in Travere Therapeutics on August 31, 2024 and sell it today you would earn a total of  94.00  from holding Travere Therapeutics or generate 5.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Viking Therapeutics  vs.  Travere Therapeutics

 Performance 
       Timeline  
Viking Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viking Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Viking Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Travere Therapeutics 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Travere Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Travere Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Viking Therapeutics and Travere Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viking Therapeutics and Travere Therapeutics

The main advantage of trading using opposite Viking Therapeutics and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.
The idea behind Viking Therapeutics and Travere Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated